MEOBF
Price:
$1.35
Market Cap:
$2.27B
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company's products under the Phase III clinical trials include remestemcel-L for the treatment of steroid refractory acute graft versus host disease, as well as acute respiratory distress syndrome due to COVID-19 infection; Rexle...[Read more]
Industry
Biotechnology
IPO Date
2010-10-15
Stock Exchange
OTC
Ticker
MEOBF
According to Mesoblast Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.23B. This represents a change of 174.33% compared to the average of 814.00M of the last 4 quarters.
The mean historical Enterprise Value of Mesoblast Limited over the last ten years is 700.17M. The current 2.23B Enterprise Value has changed 31.79% with respect to the historical average. Over the past ten years (40 quarters), MEOBF's Enterprise Value was at its highest in in the December 2024 quarter at 2.28B. The Enterprise Value was at its lowest in in the June 2025 quarter at -33001000.00.
Average
700.17M
Median
646.14M
Minimum
305.83M
Maximum
1.21B
Discovering the peaks and valleys of Mesoblast Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 107.54%
Maximum Annual Enterprise Value = 1.21B
Minimum Annual Increase = -73.32%
Minimum Annual Enterprise Value = 305.83M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.21B | 70.08% |
| 2024 | 713.46M | 23.70% |
| 2023 | 576.75M | 88.59% |
| 2022 | 305.83M | -62.77% |
| 2021 | 821.52M | -26.20% |
| 2020 | 1.11B | 107.54% |
| 2019 | 536.33M | -7.34% |
| 2018 | 578.82M | -23.81% |
| 2017 | 759.69M | 98.49% |
| 2016 | 382.73M | -73.32% |
The current Enterprise Value of Mesoblast Limited (MEOBF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
834.55M
5-year avg
726.20M
10-year avg
700.17M
Mesoblast Limited’s Enterprise Value is greater than Oxford Nanopore Technologies plc (1.08B), less than Neuren Pharmaceuticals Limited (2.45B), greater than Genus plc (1.95B), less than PeptiDream Inc. (181.74B), less than CStone Pharmaceuticals (7.45B), greater than Pharma Mar, S.A. (1.35B), greater than DocMorris AG (418.81M), less than BioArctic AB (publ) (26.67B), less than Suzuken Co., Ltd. (323.05B), greater than Stratec SE (385.03M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.08B | $1.71B | |
| 2.45B | $1.55B | |
| 1.95B | $2.32B | |
| 181.74B | $1.41B | |
| 7.45B | $1.30B | |
| 1.35B | $1.48B | |
| 418.81M | $497.46M | |
| 26.67B | $2.89B | |
| 323.05B | $1.72B | |
| 385.03M | $1.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Mesoblast Limited's Enterprise Value?
What is the highest Enterprise Value for Mesoblast Limited (MEOBF)?
What is the 3-year average Enterprise Value for Mesoblast Limited (MEOBF)?
What is the 5-year average Enterprise Value for Mesoblast Limited (MEOBF)?
How does the current Enterprise Value for Mesoblast Limited (MEOBF) compare to its historical average?